Leveraging ADCs in precision oncology strategy
Drug Target Review
MAY 27, 2024
By identifying proteins that only interact with each other in cancer, but not normal tissues, we can really expand the repertoire of ADC therapeutics beyond monoclonal antibodies developed based solely on RNA expression profiles. His work has been published in many high-impact journals and presented at international oncology meetings.
Let's personalize your content